Have you or your child been diagnosed with asthma?

Detailed Description:
This is a phase 4, randomized, double-blind, 29 week, study comparing two marketed medications, Flonase and Advair.

Inclusion Criteria includes but is not limited to:

• Patients ages 12 and older who have been diagnosed with asthma
at least one year before entering the study.
• Currently taking medication for asthma.
• Has the ability to answer questions regarding asthma status and quality of life and has the ability to use a daily electronic data capture system.
• Has ability to demonstrate proper use of metered-dose inhaler and dry powder inhaler device.